Huntsman Corporation Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Huntsman Corporation and Huntsman International LLC on November 5, 2007. The filing reports the completion of a significant asset disposition involving the sale of the company's U.S. base chemicals business assets.
Key Financial Metrics and Transaction Details
- Transaction Value: The sale to Flint Hills Resources, LP was completed for $306 million plus the value of associated inventory.
- Total Consideration: Net of other adjustments, the total consideration is approximately $415 million, subject to post-closing adjustments.
- Aggregate Deal Value: This transaction represents the second closing of a two-part sale valued at an aggregate of approximately $770 million (the first closing for U.S. polymers business assets occurred on August 1, 2007).
- Impairment Loss: The company will incur a loss of approximately $150 million in connection with this sale.
Material Changes
The primary material change is the divestiture of the U.S. base chemicals business assets. This transaction results in a recognized loss of approximately $150 million, which had been previously anticipated and disclosed in the company's Quarterly Reports on Form 10-Q for the periods ended March 31, 2007, and June 30, 2007.
Outlook, Risks, and Unusual Items
The filing includes pro forma financial information pursuant to Article 11 of Regulation S-X, attached as Exhibit 99.2, to illustrate the financial impact of the transaction. The transaction is subject to post-closing adjustments. No specific forward-looking guidance or new risk factors were introduced in this specific filing beyond the execution of the previously announced asset sale.
Key Facts for Investor Verification
- Verify the final post-closing adjustments to the $415 million total consideration.
- Review the attached Pro Forma Financial Information (Exhibit 99.2) to understand the impact on the company's balance sheet and earnings.
- Confirm the accounting treatment of the $150 million impairment loss in the upcoming quarterly earnings report.
- Assess the strategic shift resulting from the divestiture of both U.S. base chemicals and polymers businesses.